• Investment to Support Technology Roll-Out

News & Views

Investment to Support Technology Roll-Out

Jan 31 2018

Biomanufacturing company Univercells SA, (Gosselies, Belgium) has announced the successful closing of a €3 million ($3.56M) increase in a Series-A equity financing round, led by private investors from Europe and the US.

The capital injection will help enable the commercial introduction of the company’s viral micro-facility, with a first technology transfer anticipated for Q4 2018 within the framework of the Bill & Melinda Gates Foundation-supported program; it will also benefit the company’s recombinant platform development, both of which are aimed at providing a sufficient supply of high-quality biologics at an affordable price.

“We are very proud of this funding round and thankful for this wealth of support,” commented Hugues Bultot, co-founder and CEO of Univercells. “This successful capital increase is a real recognition of the work achieved so far, the innovative technology being developed and the clear expectations and roadmap set. It is highly encouraging to have seasoned industry experts demonstrate such tremendous confidence in Univercells, its ability to transform the industry with their willingness to contribute to our mission.”


Digital Edition

International Labmate 47.6 - Sept 2022

September 2022

In This Edition Chromatography Articles - Eco-Friendly RP-HPLC Mass Spectrometry & Spectroscopy Articles - Occurrence of PFAS in a variety of fish species from the Baltic Sea and freshw...

View all digital editions

Events

Dioxin 2022

Oct 09 2022 New Orleans, LA, USA

SPICA 2022

Oct 11 2022 Lisbon, Portugal

WWEM 2022

Oct 12 2022 Telford, UK

SCANAUTOMATIC

Oct 18 2022 Gothenburg, Sweden

Medlab Asia

Oct 19 2022 Bangkok, Thailand

View all events